Abbott Laboratories (ABT)

The total asset value of Abbott Laboratories (ABT) stood at $ 81,414 Mln as on 31-Dec-24

The share price of Abbott Laboratories (ABT) is $129.33 (NYSE) as of 23-Apr-2025 11:37 EDT. Abbott Laboratories (ABT) has given a return of 2.63% in the last 3 years.

Abbott Laboratories (ABT) has a market capitalisation of $ 225,271 Mln as on 22-Apr-2025. As per Value Research classification, it is a Large Cap company.

The P/E ratio of Abbott Laboratories (ABT) is 17.00 times as on 22-Apr-2025.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Abbott Laboratories (ABT) and enter the required number of quantities and click on buy to purchase the shares of Abbott Laboratories (ABT).

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Address: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400

The CEO & director of Mr. Robert B. Ford. is Abbott Laboratories (ABT), and CFO & Sr. VP is Mr. Robert B. Ford.

There is no promoter pledging in Abbott Laboratories (ABT).

Some of the close peers are:

Yes, TTM profit after tax of Abbott Laboratories (ABT) was $13,402 Mln.